Canada· CA-DIN-02459655
OTIXAL
A fluocinolon acetonid und antiinfektiva product containing fluocinolone acetonide + ciprofloxacin (ciprofloxacin hydrochloride), registered in Canada by MEDEXUS PHARMACEUTICALS INC.. The same ATC class is registered in 7 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Fluocinolon acetonid und antiinfektiva is registered in 7 of 19 countries.
Countries holding a registration under ATC S02CA05 (fluocinolon acetonid und antiinfektiva), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 5 of them publish a price we can compare per daily dose
Fluocinolon acetonid und antiinfektiva · ATC S02CA05
7 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Norwayprice
- Polandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- FLUOCINOLONE ACETONIDE + CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE)
- Manufacturer
- MEDEXUS PHARMACEUTICALS INC.
- Country
- Canada (CA)
- ATC code
- S02CA05
- ATC class
- Fluocinolon acetonid und Antiinfektiva
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fluocinolon acetonid und antiinfektiva in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandCetraxal PlusPolypharm S.A
- FinlandCetraxal CompParanova Oy
- CzechiaINFALIN DUOLaboratorios Salvat, S.A., Esplugues de Llobregat
- GermanyInfectociprocortPädia Gmbh, De, Heppenheim
- IcelandCetraxal CompPOA Pharma Scandinavia AB
- United KingdomCetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit doseAspire Pharma Ltd
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Infectociprocort
- Czechia · Infalin Duo
- Germany · Infectociprocort
- Denmark · Cetraxal Comp, Cetraxal Comp Ukonserveret
- Estonia · Bonadix
- Spain · Aceoto Plus, Cetraxal Plus
- Finland · Cetraxal Comp
- France · Cetraxal
- United Kingdom (Northern Ireland) · Cetraxal Plus
- Greece · Otospon
- Croatia · Ciprofloksacin/Flucinolonacetonid Goodwill
- Hungary · Duoxal
- Iceland · Cetraxal Comp
- Italy · Cexidal
- Lithuania · Bonadix
- Latvia · Bonadix
- Malta · Cetraxal Plus
- Norway · Cetraxal Comp
- Poland · Cetraxal Plus, Ciprotic
- Portugal · Cetraxal Duo
- Romania · Cexidal, Ototis
- Sweden · Cetraxal Comp
- Slovakia · Infalin Duo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/318b1fa7-1acb-4e4e-a568-686d19a86069 GET /v1/drugs/318b1fa7-1acb-4e4e-a568-686d19a86069?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02459655",
"form": "SOLUTION",
"class": "Human",
"routes": [
"OTIC"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "S02CA05",
"schedule": [
"Prescription"
],
"drug_code": "94696",
"strengths": [
"0.025 %",
"0.3 %"
],
"ahfs_class": null,
"substances": [
"FLUOCINOLONE ACETONIDE",
"CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE)"
],
"product_categorization": null
}See everything about fluocinolon acetonid und antiinfektiva.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.